Research and Development

BeCellBar’s Original “Tight Junction Mitigation-Closure” Technology
For “Needleless” Drug Delivery

Read More

Information

Here is information on company profiles including BeCellBar’s Mission, Business and Company Overview

Read More

Services

Screening service for regulatory compounds of tight junction
~ provide chance from incidence ~

Read More

news

Please check the latest news of BeCellBar at the following site! News Topics

Read More

Research and Development

BeCellBar’s Original “Tight Junction Mitigation-Closure” Technology For “Needleless” Drug Delivery and Therapy! Our Motivation Requirement of new drug delivery…

Read More

Information

Here is information on company profiles including BeCellBar’s Mission, Business and Company Overview ⋅BeCellBar’s Mission −Our Mission and Social…

Read More

Services

Screening service for regulatory compounds of tight junction ~ provide chance from incidence ~ This is a screening service for client…

Read More

Home

Innovation of New Technology Alternative to Injection Needle —

BeCellBar, LLC (Beyond the Cell Barrier) is a spin-out company based on research experiences established in Nagoya University.

BeCellBar develops a painless and effective delivery system for mid-size drugs without using injection needle.